Literature DB >> 12807845

Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI.

M Egred1, A Al-Mohammad, G D Waiter, T W Redpath, S K Semple, M Norton, A Welch, S Walton.   

Abstract

BACKGROUND: The identification of viable myocardium in patients with impaired left ventricular contraction secondary to coronary heart disease is important clinically as such myocardium is likely to benefit from revascularisation. Blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) relies on changes in deoxyhaemoglobin concentration under stress for signal generation and could be used for the differentiation between scarred and viable myocardium. AIM: To assess the signal change on BOLD MRI in viable and scarred myocardium as identified by positron emission tomography (PET).
METHOD: 19 patients with impaired left ventricular contraction and at least one akinetic area were enrolled. They underwent rest and dipyridamole stress MRI, using a double breath hold T2* weighted, ECG gated sequence to produce BOLD contrast images, and cine-MRI for wall thickening assessment. Dynamic perfusion and metabolic PET images followed the MRI. Signal change on BOLD MRI and the wall thickening were compared between rest and stress images in hibernating and scarred segments identified by PET on two short axis slices of mid ventricle, with eight segments each.
RESULTS: Using PET, 68 segments were identified as hibernating and 42 as scarred. The hibernating segments were found on BOLD MRI to have an average signal change between rest and stress of -9.53%, compared with -2.15% in the scarred segments (p = 0.008). The average wall thickening was 8.7 mm in the hibernating segments compared with 5.9 mm in the scarred segments (p < 0.0001).
CONCLUSIONS: BOLD MRI with wall thickening may differentiate scarred and viable myocardium and help identify suitable patients for revascularisation. Further larger studies are needed to establish a threshold for detection, sensitivity, and specificity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807845      PMCID: PMC1767717          DOI: 10.1136/heart.89.7.738

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  46 in total

1.  The relationship between the BOLD-induced T(2) and T(2)(*): a theoretical approach for the vasculature of myocardium.

Authors:  W R Bauer; W Nadler; M Bock; L R Schad; C Wacker; A Hartlep; G Ertl
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  SENSE: sensitivity encoding for fast MRI.

Authors:  K P Pruessmann; M Weiger; M B Scheidegger; P Boesiger
Journal:  Magn Reson Med       Date:  1999-11       Impact factor: 4.668

Review 3.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

4.  Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography.

Authors:  H R Schelbert; M E Phelps; E J Hoffman; S C Huang; C E Selin; D E Kuhl
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

5.  The dependence of accumulation of 13NH3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion.

Authors:  S R Bergmann; S Hack; T Tewson; M J Welch; B E Sobel
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

6.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

Authors:  E Wu; R M Judd; J D Vargas; F J Klocke; R O Bonow; R J Kim
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

7.  Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements.

Authors:  C M Wacker; M Bock; A W Hartlep; G Beck; G van Kaick; G Ertl; W R Bauer; L R Schad
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

8.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

9.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

Authors:  D Eitzman; Z al-Aouar; H L Kanter; J vom Dahl; M Kirsh; G M Deeb; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094

Review 10.  The hibernating myocardium in ischaemia and congestive heart failure.

Authors:  S H Rahimtoola
Journal:  Eur Heart J       Date:  1993-07       Impact factor: 29.983

View more
  11 in total

Review 1.  Future prospects in magnetic resonance imaging.

Authors:  Mark Doyle; Robert W W Biederman
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 2.  CMR for characterization of the myocardium in acute coronary syndromes.

Authors:  Erica Dall'Armellina; Theodoros D Karamitsos; Stefan Neubauer; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2010-09-21       Impact factor: 32.419

3.  Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality.

Authors:  Surya C Gnyawali; Sashwati Roy; Molly McCoy; Sabyasachi Biswas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 4.  Three-dimensional contrast-enhanced and non-contrast-enhanced cardiac magnetic resonance imaging for the assessment of myocardial ischemic reactions: the practice of looking deeply into the myocardium.

Authors:  Cosima Jahnke; Sebastian Kozerke; Bernhard Schnackenburg; Nikolaus Marx; Ingo Paetsch
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

5.  Myocardial Tissue Oxygenation and Microvascular Blood Volume Measurement Using a Contrast Blood Oxygenation Level-Dependent Imaging Model.

Authors:  Jeffrey M Dendy; Sean G Hughes; Jonathan H Soslow; Daniel E Clark; Cynthia B Paschal; John C Gore
Journal:  Invest Radiol       Date:  2022-04-13       Impact factor: 10.065

6.  Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis.

Authors:  Ning Jin; Jie Deng; Tamuna Chadashvili; Yue Zhang; Yang Guo; Zhuoli Zhang; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

Review 7.  Improving Cell Engraftment in Cardiac Stem Cell Therapy.

Authors:  Xiaofei Li; Kenichi Tamama; Xiaoyun Xie; Jianjun Guan
Journal:  Stem Cells Int       Date:  2015-12-13       Impact factor: 5.443

8.  Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells.

Authors:  Yong-Seok Han; Jun Hee Lee; Yeo Min Yoon; Chul Won Yun; Hyunjin Noh; Sang Hun Lee
Journal:  Cell Death Dis       Date:  2016-10-06       Impact factor: 8.469

9.  Long-term stability of cardiac function in normal and chronically failing mouse hearts in a vertical-bore MR system.

Authors:  Jürgen E Schneider; Karen J Hulbert; Craig A Lygate; Michiel Ten Hove; Paul J Cassidy; Kieran Clarke; Stefan Neubauer
Journal:  MAGMA       Date:  2004-11-08       Impact factor: 2.310

10.  Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.

Authors:  Susie Parnham; Jonathan M Gleadle; Sripal Bangalore; Suchi Grover; Rebecca Perry; Richard J Woodman; Carmine G De Pasquale; Joseph B Selvanayagam
Journal:  J Am Heart Assoc       Date:  2015-08-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.